Clinical Trial Update: Autologous OC-DC Vaccine in Ovarian Cancer [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study of an autologous OC-DC dendritic cell vaccine in ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Autologous OC-DC vaccine

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Chemotherapy, Tumor | EARLY_Phase 1 | Status: COMPLETED